AI-Native Precision Medicine
Dynamic, interpretable, AI-powered intelligence to predict treatment response and outsmart resistance.
Gaps in medicine we solve
We turn fragmented data into continuous, personalized treatment intelligence.
Track treatment response in real time, without invasive procedures.
Integrate genomic, clinical, and longitudinal data into one view.
Reveal the biological drivers behind every prediction.
Identify responders early and guide go/no-go decisions with confidence.
We built a computational framework that enables each step of personalized medicine, from multi-modal data integration to biomarker development to forecasting cancer outcomes, delivered as actionable clinical reports that guide therapy decisions.
While MRD and risk scores look backward, we deliver forward-looking therapy selection and resistance-blocking insight for any cancer type.
We deliver target identification, early activity/futility markers, and smarter trial designs that reduce risk, sample size, and time.
Our Platform
Intelligence Layer
Integrate multi-modal data, develop biomarkers, and forecast outcomes, delivered as clinical-ready reports.
Intelligence Layer
Integrate multi-modal data, develop biomarkers, and forecast outcomes, delivered as clinical-ready reports.
Endorse bx
RNA/DNA-seq from biopsy stratifies endocrine therapy response at any stage: interpretable, clinic-ready, automated biopsy-to-report.
Endorse bx
RNA/DNA-seq from biopsy stratifies endocrine therapy response at any stage: interpretable, clinic-ready, automated biopsy-to-report.
Introducing Unravel Journey
AI-powered genomic biomarker monitoring with your personalised AI Care Plan. Your Cancer Journey includes EndorseScore, Immune score, and mTOR-Score with longitudinal cancer trajectory.
Our Science
Published in Nature Cancer, Nature Communications, and Molecular Systems Biology.
Explore Unravel
Predictive biomarkers and interpretable AI for clinical decision support: track response over time and spot resistance earlier, not as a one-off lab readout.
Predictive biomarkers and interpretable AI for clinical decision support: track response over time and spot resistance earlier, not as a one-off lab readout.
Partner with Unravel Genomics to leverage dynamic, AI-powered biomarkers for treatment response prediction and resistance management.
